Tirzepatide is a novel medication approved by the US Food and Drug Administration (FDA) for treating type 2 diabetes mellitus (T2DM). This medication also demonstrates efficacy in weight loss, leading to its off-label use for obesity treatment.
Product composition Tirzepatide
•5/10/15 mg of active substance with a high degree of chemical purity – analytical substance, for research.
Tirzepatide storage conditions
The vial with powder should be stored at room temperature and in a dark place. After diluting the product with bacteriostatic water or physiological saline, the substance should be stored at a temperature of 2°C to 6°C.
3 reviews for TIRZEPATIDE 5/10/15MG